Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation

Perfusion

Volumn 22, Issue 3, 2007, Pages 193-200

  Skrzypchak, Amy M ^a   Lafayette, Nathan G ^a   Bartlett, Robert H ^a   Zhou, Zhengrong ^b   Frost, Megan C ^b   Meyerhoff, Mark E ^b   Reynolds, Melissa M ^c   Annich, Gail M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MC3 Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HEPARIN; NITRIC OXIDE; POLYVINYLCHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FIBRINOGEN BLOOD LEVEL; IN VIVO STUDY; INTRAVENOUS CATHETER; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; RABBIT; REFERENCE VALUE; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOGENESIS; VASCULAR ACCESS;

ANIMALS; BLOOD PLATELETS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; EXTRACORPOREAL CIRCULATION; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE DONORS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET COUNT; POLYVINYL CHLORIDE; RABBITS;

EID: 35549000120     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107080877     Document Type: Article

References (26)

1. Miskulin J, Annich G, Gillian C, et al. NO flux determines thromboresistance in NO-releasing extracorporeal circuits. ASAIO J 2002; 48(2): 145 (poster presentation ASAIO, New York 2002).
2. Skrzypchak AM, Miskulin J, Bartlett RH, Annich GM. The development of a small animal model of extracorporeal circulation. ASAIO J 2006; 52(3): 296-302.
3. van Oeveren W, Wildevuur CRH. Blood compatibility of cardiopulmonary bypass circuits. Perfusion 1987; 2: 237-44.
4. Gallimore MJ, Heller W, Fuhrer G, Wendel HP, Klaffschenkel R, Hoffmeister HE. Contact activation, heparins and cardiopulmonary bypass. Thromb Haemost 1992; 68: 91-92.
5. Hennessy Jr. VL, Hicks RE, Nierwiarowski S, et al. Function of human platelets during extracorporeal circulation. Am J Physiol 1997; 232: H622-H628.
6. Robinson TM, Kickler TS, Walker LK, et al. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 1983; 21: 1029-34.
7. ECMO Registry of the Extracorporeal Life Support Organization (ELSO), Ann Arbor, Michigan, April, 2006.
8. Gorman RC, Ziats NP, Rao AK, et al. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 557-58.
9. Edmunds Jr. LH, Stenach N. The blood-surface interface. In Gravlee GP, Davis RF, Kurusz M, Utley JR eds. Cardiopulmonary bypass, principles and practice. 2nd edn. Pennsylvania, Williams & Wilkins, 1999: 150-66.
10. Plotz FB, Wildevuur WR, Wildevuur CRH, et al. Platelet consumption during neonatal extracorporeal life support (ECLS). Perfusion 1992; 7: 27-32.
11. Salzman EW, Rosenberg RD, Smith MH, et al. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64-73.
12. Annich GM, Meinhardt JP, Mowery KA, et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 2000; 28(4): 915-20.
13. Reynolds MM, Frost MC, Meyerhoff ME. Nitric oxide-releasing hydrophobic polymers: preparation, characterization, and potential biomedical applications. Free Radic Biol Med 2004; 37(7): 926-36.
14. Moncada S, Palmer RMJ. Biosynthesis and actions of nitric oxide. Semin Perinatol 1991; 15:16-19.
15. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 1993; 344: 251-65.
16. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148(3): 1482-89.
17. Vaughn MW, Kuo L, Liao JC. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J Physiol 1998; 274: H2163-76.
18. Zhang H, Merz SI, Annich GM, et al. Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluations. Biomaterials 2002; 23: 1485-94.
19. Zhang H, Annich GM, Miskulin J, et al. Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. J Am Chem Soc 2003; 125: 5015-24.
20. Weiss DJ. Comparative physiology of platelets from different species. In Rao HR ed. Handbook of platelet physiology and pharmacology. Boston, Kluwer Academic Publishers, 1999: 379-93.
21. Day HJ, Rao AK. Evaluation of platelet function. Semin Hematol 1986; 23(2): 89-101.
22. Espadas-Torre C. Controlled release of platelet-inhibiting nitric oxide from functional polymeric ion-selective membranes containing nitric oxide donors. [Doctoral Thesis] Ann Arbor, MI, University of Michigan, 1996: 70-108.
23. Haisch CE, Parker F, Brown P. Section XII Chapter 69: Vascular. In Sabiston text of surgery, 17th edn. Townsend, Saunders, 2004: 2089-90.
24. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-703.
25. Blackstone EH, Kirklin JW, Stewart RW, Chenoweth DE. The damaging effects of cardiopulmonary bypass. In Wu KK, Roxy EC eds. Prostaglandins in clinical medicine: cardiovascular and thrombotic disorders. Chicago, Yearbook Medical Publishers Inc., 1982: 355.
26. Fleser PS, Nuthakki VK, Malinzak LE, et al. Nitric oxide releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J Vasc Surg 2004; 40: 803-11.